Tuberculosis and Respiratory Diseases

The Korean Academy of Tuberculosis and Respiratory Diseases (대한결핵및호흡기학회)
권호 표지
DOI QR코드

DOI QR Code

A Case of Isolated Pulmonary Mucormycosis in an Immunocompetent Host

  • Lee, Jung Su (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Ho Cheol (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Park, Sang Woo (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • So, Hoon Sub (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Woo, Chang Yun (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Choi, Jong Han (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Sang Hyung (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine) ;
  • Kim, Se Jin (Division of Pulmonary Medicine, Department of Internal Medicine, The Armed Forced Capital Hospital) ;
  • Oh, Yeon-Mok (Department of Medicine, Asan Medical Center, University of Ulsan College of Medicine)
  • Received : 2012.09.10
  • Accepted : 2012.10.11
  • Published : 2013.06.30
Download PDF
⟨ Previous Next ⟩

Abstract

Mucormycosis is a rare fungal disease that holds a fatal opportunistic fungal infection in diabetes mellitus, hematological malignancy, and immunocompromised host. Isolated pulmonary mucormycosis is extremely rare. Optimal therapy is a combined medical-surgical approach and a management of the patient's underlying disease. Herein, we report a case-study of isolated pulmonary mucormycosis which was being presented as multiple lung nodules in a patient with no underlying risk factors. Considering that the patient had poor pulmonary functions, we treated him with only antifungal agent rather than a combined medical-surgical approach. After treatment with antifungal agent for six months, the nodules of pulmonary mucormycosis were improved with the prominent reductions of size on the computed tomography.

Keywords

References

  1. Butala A, Shah B, Cho YT, Schmidt MF. Isolated pulmonary mucormycosis in an apparently normal host: a case report. J Natl Med Assoc 1995;87:572-4.
  2. Ibrahim AS, Spellberg B, Walsh TJ, Kontoyiannis DP. Pathogenesis of mucormycosis. Clin Infect Dis 2012;54 Suppl 1:S16-22. https://doi.org/10.1093/cid/cir865
  3. Petrikkos G, Skiada A, Lortholary O, Roilides E, Walsh TJ, Kontoyiannis DP. Epidemiology and clinical manifestations of mucormycosis. Clin Infect Dis 2012;54 Suppl 1:S23-34. https://doi.org/10.1093/cid/cir866
  4. Kim TJ, Park CY, Jin YG, Park KE, Her KM, Kim YH, et al. A case of pulmonary mucormycosis associated uncontrolled diabetes mellitus. Korean J Med 1997; 53(Suppl 3):S792-6.
  5. Lee SJ, Yoon SJ, Kim EJ, Cha SI, Park JY, Jung TH, et al. A case of pulmonary mucormycosis complicated by pneumomediastinum and subcutaneous emphysema after chemotherapy in a patient with small cell lung cancer. Korean J Med 2007;72:551-7.
  6. Pagano L, Offidani M, Fianchi L, Nosari A, Candoni A, Piccardi M, et al. Mucormycosis in hematologic patients. Haematologica 2004;89:207-14.
  7. Cho YJ, Kang MH, Kim HS, Jeong YY, Jang IS, Kim HC, et al. A case of angio-invasive pulmonary mucormycosis with uncontrolled diabetes mellitus. Tuberc Respir Dis 2008;64:451-5. https://doi.org/10.4046/trd.2008.64.6.451
  8. Spellberg B, Kontoyiannis DP, Fredricks D, Morris MI, Perfect JR, Chin-Hong PV, et al. Risk factors for mortality in patients with mucormycosis. Med Mycol 2012;50: 611-8. https://doi.org/10.3109/13693786.2012.669502
  9. Hamilos G, Samonis G, Kontoyiannis DP. Pulmonary mucormycosis. Semin Respir Crit Care Med 2011;32: 693-702. https://doi.org/10.1055/s-0031-1295717

Cited by

  1. Gastric Mucormycosis Followed by Traumatic Cardiac Rupture in an Immunocompetent Patient vol.68, pp.2, 2013, https://doi.org/10.4166/kjg.2016.68.2.99
  2. Characteristics of pulmonary mucormycosis and predictive risk factors for the outcome vol.46, pp.4, 2013, https://doi.org/10.1007/s15010-018-1149-x
  3. Pulmonary mucormycosis in a patient with acute liver failure: A case report and systematic review of the literature vol.56, pp.None, 2020, https://doi.org/10.1016/j.jcrc.2019.12.012
  4. Isolated pulmonary mucormycosis in an immunocompetent patient: a case report and systematic review of the literature vol.21, pp.1, 2021, https://doi.org/10.1186/s12890-021-01504-8
  5. Rhizopus microsporus lung infection in an immunocompetent patient successfully treated with amphotericin B: A case report vol.9, pp.35, 2013, https://doi.org/10.12998/wjcc.v9.i35.11108